3GGU
HIV PR drug resistant patient's variant in complex with darunavir
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A, B (A, B) | Protease | polymer | 99 | 10953.7 | 2 | UniProt (P03367) Pfam (PF00077) | Human immunodeficiency virus type 1 (BRU ISOLATE) | |
| 2 | C (B) | (3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE | non-polymer | 547.7 | 1 | Chemie (017) | |||
| 3 | D, E (A, B) | water | water | 18.0 | 142 | Chemie (HOH) |
Sequence modifications
A, B: 1 - 99 (UniProt: P03367)
| PDB | External Database | Details |
|---|---|---|
| Ile 10 | Leu 510 | engineered mutation |
| Val 13 | Ile 513 | engineered mutation |
| Glu 16 | Gly 516 | engineered mutation |
| Phe 33 | Leu 533 | engineered mutation |
| Leu 36 | Met 536 | engineered mutation |
| Thr 37 | Ser 537 | engineered mutation |
| Ser 39 | Pro 539 | engineered mutation |
| Arg 45 | Lys 545 | engineered mutation |
| Leu 46 | Met 546 | engineered mutation |
| Val 54 | Ile 554 | engineered mutation |
| Arg 55 | Lys 555 | engineered mutation |
| Val 62 | Ile 562 | engineered mutation |
| Pro 63 | Leu 563 | engineered mutation |
| Val 71 | Ala 571 | engineered mutation |
| Asp 73 | Gly 573 | engineered mutation |
| Thr 82 | Val 582 | engineered mutation |
| Val 84 | Ile 584 | engineered mutation |
| Val 89 | Leu 589 | engineered mutation |
| Met 90 | Leu 590 | engineered mutation |
| Leu 93 | Ile 593 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 2 |
| Total formula weight | 21907.4 | |
| Non-Polymers* | Number of molecules | 1 |
| Total formula weight | 547.7 | |
| All* | Total formula weight | 22455.1 |






